Demant A/S (WILYY) Stock Price, News & Analysis

Company Overview

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss. Its activities span hearing aids, audiological diagnostic equipment, hearing-related communications solutions and professional hearing care services.

The company’s hearing aid portfolio includes brands such as Oticon, Bernafon and Sonic, as well as Philips Hearing Solutions products developed through a licensing partnership. Demant also supplies diagnostic equipment through brands including Interacoustics, MAICO, Grason-Stadler and MedRx. Through hearing care operations and retail networks, including Audika and HearingLife in selected markets, the company provides hearing assessments, fitting, rehabilitation and related patient services.

Founded in 1904 by Hans Demant after he sought a hearing aid for his wife, the company has grown into an international hearing healthcare group headquartered in Smørum, Denmark. It changed its name from William Demant Holding A/S to Demant A/S in 2019. Demant serves customers through operations and distribution networks across Europe, North America, Asia-Pacific and other international markets, with Søren Nielsen serving as president and chief executive officer.

Key Stats

• Today's Range: $23.85 to $23.85
• 50-Day Range: $20.66 to $23.85
• 52-Week Range: $13.45 to $23.85
• Volume: 1 shs
• Average Volume: 365 shs
• Market Capitalization: $10.10 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Demant A/S Stock Analysis - MarketRank™

Demant A/S scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Demant A/S has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 strong buy rating, 1 buy rating, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Demant A/S has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 12.15%

Earnings Growth

Earnings for Demant A/S are expected to grow by 12.15% in the coming year, from $1.07 to $1.20 per share.

Price to Book Value per Share Ratio

Demant A/S has a P/B Ratio of 6.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Demant A/S has been sold short.

Short Interest Ratio / Days to Cover

Demant A/S has a short interest ratio ("days to cover") of 3.37, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Demant A/S has recently decreased by 24.59%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Demant A/S does not currently pay a dividend.

Dividend Growth

Demant A/S does not have a long track record of dividend growth.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: N/A

News Sentiment

Demant A/S has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Demant A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Demant A/S has minimal institutional ownership at this time.

Company Calendar

• Today: 9/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WILYY
• Previous Symbol: NASDAQ:WILYY
• CIK: N/A
• Web: www.demant.com
• Phone: (453) 917-7300
• Fax: 45-3927-8900
• Employees: 26,704
• Year Founded: 1904

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.65
• Current Ratio: 1.36
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $3.48 billion
• Price / Sales: 2.90
• Cash Flow: $0.88 per share
• Price / Cash Flow: 27.13
• Book Value: $3.51 per share
• Price / Book: 6.79

Miscellaneous

• Outstanding Shares: 423,510,000
• Free Float: N/A
• Market Cap: $10.10 billion
• Optionable: Not Optionable
• Beta: 1.20